ACB
Price
$5.57
Change
+$0.20 (+3.72%)
Updated
Jun 4 closing price
Capitalization
238.86M
14 days until earnings call
SHIEF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jun 3 closing price
Capitalization
98.52M
Interact to see
Advertisement

ACB vs SHIEF

Header iconACB vs SHIEF Comparison
Open Charts ACB vs SHIEFBanner chart's image
Aurora Cannabis
Price$5.57
Change+$0.20 (+3.72%)
Volume$625.33K
Capitalization238.86M
Shield Therapeutics
Price$0.03
Change-$0.00 (-0.00%)
Volume$4K
Capitalization98.52M
ACB vs SHIEF Comparison Chart
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACB vs. SHIEF commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a Buy and SHIEF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (ACB: $5.57 vs. SHIEF: $0.03)
Brand notoriety: ACB: Notable vs. SHIEF: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACB: 67% vs. SHIEF: 100%
Market capitalization -- ACB: $238.86M vs. SHIEF: $98.52M
ACB [@Pharmaceuticals: Other] is valued at $238.86M. SHIEF’s [@Pharmaceuticals: Other] market capitalization is $98.52M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileSHIEF’s FA Score has 0 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • SHIEF’s FA Score: 0 green, 5 red.
According to our system of comparison, ACB is a better buy in the long-term than SHIEF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 4 TA indicator(s) are bullish.

  • ACB’s TA Score: 4 bullish, 5 bearish.

Price Growth

ACB (@Pharmaceuticals: Other) experienced а +0.91% price change this week, while SHIEF (@Pharmaceuticals: Other) price change was -2.65% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.47%. For the same industry, the average monthly price growth was +15.01%, and the average quarterly price growth was +59.84%.

Reported Earning Dates

ACB is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.47% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACB($239M) has a higher market cap than SHIEF($98.5M). ACB YTD gains are higher at: 31.059 vs. SHIEF (-4.058). SHIEF has higher annual earnings (EBITDA): -21.41M vs. ACB (-1.64B). ACB has more cash in the bank: 149M vs. SHIEF (2.4M). SHIEF has less debt than ACB: SHIEF (0) vs ACB (103M). ACB has higher revenues than SHIEF: ACB (212M) vs SHIEF (3.07M).
ACBSHIEFACB / SHIEF
Capitalization239M98.5M243%
EBITDA-1.64B-21.41M7,645%
Gain YTD31.059-4.058-765%
P/E RatioN/AN/A-
Revenue212M3.07M6,908%
Total Cash149M2.4M6,198%
Total Debt103M0-
FUNDAMENTALS RATINGS
ACB vs SHIEF: Fundamental Ratings
ACB
SHIEF
OUTLOOK RATING
1..100
1695
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
85
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8994
PRICE GROWTH RATING
1..100
4652
P/E GROWTH RATING
1..100
7393
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACB's Valuation (58) in the Pharmaceuticals Other industry is in the same range as SHIEF (85) in the null industry. This means that ACB’s stock grew similarly to SHIEF’s over the last 12 months.

ACB's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as SHIEF (100) in the null industry. This means that ACB’s stock grew similarly to SHIEF’s over the last 12 months.

ACB's SMR Rating (89) in the Pharmaceuticals Other industry is in the same range as SHIEF (94) in the null industry. This means that ACB’s stock grew similarly to SHIEF’s over the last 12 months.

ACB's Price Growth Rating (46) in the Pharmaceuticals Other industry is in the same range as SHIEF (52) in the null industry. This means that ACB’s stock grew similarly to SHIEF’s over the last 12 months.

ACB's P/E Growth Rating (73) in the Pharmaceuticals Other industry is in the same range as SHIEF (93) in the null industry. This means that ACB’s stock grew similarly to SHIEF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACB
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAPS1.050.01
+0.96%
WM Technology
ALBT3.50N/A
N/A
Avalon GloboCare Corp
VINP9.63-0.05
-0.52%
Vinci Partners Investments Ltd
EXEL42.22-0.45
-1.05%
Exelixis
AGL2.19-0.08
-3.52%
agilon health

ACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACB has been closely correlated with CGC. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACB jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
+3.72%
CGC - ACB
68%
Closely correlated
+7.44%
SNDL - ACB
65%
Loosely correlated
+0.78%
OGI - ACB
60%
Loosely correlated
+0.75%
CRON - ACB
58%
Loosely correlated
N/A
TLRY - ACB
57%
Loosely correlated
+2.17%
More

SHIEF and

Correlation & Price change

A.I.dvisor tells us that SHIEF and TLRY have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHIEF and TLRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHIEF
1D Price
Change %
SHIEF100%
N/A
TLRY - SHIEF
28%
Poorly correlated
+2.17%
CGC - SHIEF
26%
Poorly correlated
+7.44%
ACB - SHIEF
25%
Poorly correlated
+3.72%
IMCC - SHIEF
25%
Poorly correlated
-4.51%
CVSI - SHIEF
20%
Poorly correlated
-2.61%
More